Trademark: 85307268
Word
EDARBYCHLOR
Status
Dead
Status Code
606
Status Date
Monday, September 3, 2012
Serial Number
85307268
Mark Type
4000
Filing Date
Thursday, April 28, 2011
Published for Opposition
Tuesday, December 6, 2011
Abandoned Date
Monday, September 3, 2012

Trademark Owner History
Takeda Pharmaceutical Company Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders
E DARBY CHLOR
The wording "EDARBYCHLOR" has no meaning in a foreign language.

Trademark Events
Sep 4, 2012
Abandonment Notice Mailed - No Use Statement Filed
Sep 3, 2012
Abandonment - No Use Statement Filed
Jan 31, 2012
Noa E-Mailed - Sou Required From Applicant
Dec 6, 2011
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2011
Published For Opposition
Nov 16, 2011
Notification Of Notice Of Publication E-Mailed
Nov 2, 2011
Law Office Publication Review Completed
Oct 28, 2011
Approved For Pub - Principal Register
Oct 26, 2011
Teas/Email Correspondence Entered
Oct 26, 2011
Correspondence Received In Law Office
Oct 20, 2011
Assigned To Lie
Oct 14, 2011
Teas Response To Office Action Received
Aug 9, 2011
Notification Of Non-Final Action E-Mailed
Aug 9, 2011
Non-Final Action E-Mailed
Aug 9, 2011
Non-Final Action Written
Aug 9, 2011
Assigned To Examiner
May 5, 2011
Notice Of Pseudo Mark Mailed
May 4, 2011
New Application Office Supplied Data Entered In Tram
May 2, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24